Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice

Maria F Falangola1, Sang-Pil Lee, Ralph A Nixon

  • 1Center for Advanced Brain Imaging, Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA. falangola@nki.rfmh.org

Insights

Iron is present in beta-amyloid plaques in a mouse model of Alzheimer's disease (AD). This finding may explain MRI signal changes observed in AD patients, linking iron accumulation to plaque visibility.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Medical Imaging

Background:

  • Alzheimer's disease (AD) is characterized by beta-amyloid (Abeta) plaques.
  • Iron accumulation has been observed in AD brains, but its direct association with plaques is debated.
  • Magnetic Resonance Imaging (MRI) studies show altered signal intensities in AD, potentially linked to plaque composition.

Purpose of the Study:

  • To confirm the presence and location of iron within Abeta plaques in a transgenic mouse model of AD.
  • To investigate the impact of histological fixation and sectioning on iron detection methods.
  • To explore the role of iron in Abeta plaque-associated MRI contrast.

Main Methods:

  • Utilized Perls' stain for Fe3+ detection.
  • Combined with 3,3'-diaminobenzidine (DAB) and Abeta immunohistochemistry.
  • Examined brain sections from PS/APP transgenic mice fixed with formalin or methacarn.

Main Results:

  • Confirmed iron co-localization with Abeta plaques in PS/APP mouse brains.
  • Demonstrated that fixation methods and slice thickness did not impede Perls' staining.
  • Established iron as a component of beta-amyloid plaques in this AD model.

Conclusions:

  • Iron is a constituent of beta-amyloid plaques in the PS/APP mouse model.
  • This iron presence likely contributes to the reduced transverse relaxation time (T2) observed in MRI studies.
  • Iron within plaques may be the source of intrinsic MR contrast for Abeta plaques in AD models.

Related Concept Videos